These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Physicochemical and morphological characterization of polyisobutyl cyanoacrylate nanocapsules. Rollot JM; Couvreur P; Roblot-Treupel L; Puisieux F J Pharm Sci; 1986 Apr; 75(4):361-4. PubMed ID: 3723356 [TBL] [Abstract][Full Text] [Related]
3. Effects of formulation variables on characteristics of poly (ethylcyanoacrylate) nanocapsules prepared from w/o microemulsions. Watnasirichaikul S; Rades T; Tucker IG; Davies NM Int J Pharm; 2002 Mar; 235(1-2):237-46. PubMed ID: 11879758 [TBL] [Abstract][Full Text] [Related]
4. The stability and controlled release of I-ascorbic acid encapsulated in poly (ethyl-2-cyanoacrylate) nanocapsules prepared by interfacial polymerization of water-in-oil microemulsions. Zhang SN; Chen T; Guo YG; Zhang J; Song X; Zhou L J Cosmet Sci; 2015; 66(4):247-59. PubMed ID: 26665980 [TBL] [Abstract][Full Text] [Related]
5. Optimization of paeonol-loaded poly(butyl-2-cyanoacrylate) nanocapsules by central composite design with response surface methodology together with the antibacterial properties. Yao J; Zhang Y; Hu Q; Zeng D; Hua F; Meng W; Wang W; Bao GH Eur J Pharm Sci; 2017 Apr; 101():189-199. PubMed ID: 28189814 [TBL] [Abstract][Full Text] [Related]
6. Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides. Lambert G; Fattal E; Pinto-Alphandary H; Gulik A; Couvreur P Pharm Res; 2000 Jun; 17(6):707-14. PubMed ID: 10955845 [TBL] [Abstract][Full Text] [Related]
7. Interfacial properties of polymethyl alpha-cyanoacrylate and polybutyl alpha-cyanoacrylate. Florence AT; Haq ME; Johnson JR J Pharm Pharmacol; 1976 Jul; 28(7):539-43. PubMed ID: 8604 [TBL] [Abstract][Full Text] [Related]
9. Core-shell type of nanoparticles composed of poly[(n-butyl cyanoacrylate)-co-(2-octyl cyanoacrylate)] copolymers for drug delivery application: synthesis, characterization and in vitro degradation. Huang CY; Lee YD Int J Pharm; 2006 Nov; 325(1-2):132-9. PubMed ID: 16857330 [TBL] [Abstract][Full Text] [Related]
10. Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties. Couvreur P; Kante B; Roland M; Guiot P; Bauduin P; Speiser P J Pharm Pharmacol; 1979 May; 31(5):331-2. PubMed ID: 37304 [No Abstract] [Full Text] [Related]
11. In-vitro release and oral bioactivity of insulin in diabetic rats using nanocapsules dispersed in biocompatible microemulsion. Watnasirichaikul S; Rades T; Tucker IG; Davies NM J Pharm Pharmacol; 2002 Apr; 54(4):473-80. PubMed ID: 11999123 [TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of polyethyl-2-cyanoacrylate nanocapsules containing antiepileptic drugs. Fresta M; Cavallaro G; Giammona G; Wehrli E; Puglisi G Biomaterials; 1996 Apr; 17(8):751-8. PubMed ID: 8730958 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of polyalkylcyanoacrylate nanoparticles as a potential drug carrier: preparation, morphological characterization and loading capacity. Puglisi G; Giammona G; Fresta M; Carlisi B; Micali N; Villari A J Microencapsul; 1993; 10(3):353-66. PubMed ID: 8377093 [TBL] [Abstract][Full Text] [Related]
14. Effects of external phase on D-cycloserine loaded W/O nanocapsules prepared by the interfacial polymerization method. Musumeci T; Ventura CA; Carbone C; Pignatello R; Puglisi G Eur J Med Chem; 2011 Jul; 46(7):2828-34. PubMed ID: 21530017 [TBL] [Abstract][Full Text] [Related]
15. Poly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release and in vivo skin penetration. Miyazaki S; Takahashi A; Kubo W; Bachynsky J; Löebenberg R J Pharm Pharm Sci; 2003; 6(2):238-45. PubMed ID: 12935436 [TBL] [Abstract][Full Text] [Related]
17. New approach to hydrophobic cyanine-type photosensitizer delivery using polymeric oil-cored nanocarriers: hemolytic activity, in vitro cytotoxicity and localization in cancer cells. Pietkiewicz J; Zielińska K; Saczko J; Kulbacka J; Majkowski M; Wilk KA Eur J Pharm Sci; 2010 Mar; 39(5):322-35. PubMed ID: 20060468 [TBL] [Abstract][Full Text] [Related]
18. Using different structure types of microemulsions for the preparation of poly(alkylcyanoacrylate) nanoparticles by interfacial polymerization. Krauel K; Davies NM; Hook S; Rades T J Control Release; 2005 Aug; 106(1-2):76-87. PubMed ID: 15967536 [TBL] [Abstract][Full Text] [Related]
19. Poly(alkyl cyanoacrylate) nanocapsules as a delivery system in the rat for octreotide, a long-acting somatostatin analogue. Damgé C; Vonderscher J; Marbach P; Pinget M J Pharm Pharmacol; 1997 Oct; 49(10):949-54. PubMed ID: 9364401 [TBL] [Abstract][Full Text] [Related]
20. Artificial oxygen carriers based on perfluorodecalin-filled poly(n-butyl-cyanoacrylate) nanocapsules. Stephan C; Schlawne C; Grass S; Waack IN; Ferenz KB; Bachmann M; Barnert S; Schubert R; Bastmeyer M; de Groot H; Mayer C J Microencapsul; 2014; 31(3):284-92. PubMed ID: 24124886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]